Colognori, David http://orcid.org/0000-0001-6995-7079
Trinidad, Marena
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Funding for this research was provided by:
Howard Hughes Medical Institute
Jane Coffin Childs Memorial Fund for Medical Research
Article History
Received: 1 June 2022
Accepted: 15 December 2022
First Online: 23 January 2023
Competing interests
: The Regents of the University of California have filed a related patent, for which D.C. and J.A.D. are inventors, on the use of the Csm system for eukaryotic RNA KD with the United States Patent and Trademark Office. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Intellia Therapeutics and Mammoth Biosciences, and a director of Johnson & Johnson, Altos Labs and Tempus. J.A.D. is a scientific advisor to Caribou Biosciences, Intellia Therapeutics, Mammoth Biosciences, Scribe Therapeutics, Algen, Felix and Inari; J.A.D. serves on the scientific advisory boards of Sixth Street and The Column Group. J.A.D. has research projects sponsored by Roche and Apple Tree Partners. The other author declares no competing interests.